As promised in our earlier post (see "Professor Sarnoff Provides His Perspective on Tillis Bill"), here we turn to Professor Joshua Sarnoff’s thoughts on the portions of Senator Thom Tillis’ (R-NC) bill regarding diagnostic method patents. Those thoughts were presented in abbreviated form in the earlier post because we did not have the space the discussion deserved. Here they are in full, followed by Kevin Noonan’s response. Professor Sarnoff: Kevin posits that Mayo (and implicitly Myriad) have adversely affected innovation in diagnostic methods. Perhaps Kevin is right in regard to venture and other capital investments in developing such methods (but…
